(2R)-2-[[5-(5-fluoro-3-pyridinyl)-3-methylpyrazolo[1,5-a]pyrimidin-7-yl]amino]-3-(1H-indol-3-yl)-N-methylpropanamide
C24H22FN7O — CID 142460267
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-[[5-(5-fluoro-3-pyridinyl)-3-methylpyrazolo[1,5-a]pyrimidin-7-yl]amino]-3-(1H-indol-3-yl)-N-methylpropanamide
(2R)-2-[[5-(5-fluoro-3-pyridinyl)-3-methylpyrazolo[1,5-a]pyrimidin-7-yl]amino]-3-(1H-indol-3-yl)-N-methylpropanamide (PubChem CID 142460267) has the molecular formula C24H22FN7O and a molecular weight of 443.49 g/mol. Its IUPAC name is (2R)-2-[[5-(5-fluoro-3-pyridinyl)-3-methylpyrazolo[1,5-a]pyrimidin-7-yl]amino]-3-(1H-indol-3-yl)-N-methylpropanamide.
Molecular Properties
| Compound Name | (2R)-2-[[5-(5-fluoro-3-pyridinyl)-3-methylpyrazolo[1,5-a]pyrimidin-7-yl]amino]-3-(1H-indol-3-yl)-N-methylpropanamide |
|---|---|
| PubChem CID | 142460267 |
| Molecular Formula | C24H22FN7O |
| Molecular Weight | 443.49 g/mol |
| Exact Mass | 443.19 |
| IUPAC Name | (2R)-2-[[5-(5-fluoro-3-pyridinyl)-3-methylpyrazolo[1,5-a]pyrimidin-7-yl]amino]-3-(1H-indol-3-yl)-N-methylpropanamide |
| SMILES | CNC(=O)[C@@H](Cc1c[nH]c2ccccc12)Nc1cc(-c2cncc(F)c2)nc2c(C)cnn12 |
| InChI | InChI=1S/C24H22FN7O/c1-14-10-29-32-22(9-20(31-23(14)32)16-7-17(25)13-27-11-16)30-21(24(33)26-2)8-15-12-28-19-6-4-3-5-18(15)19/h3-7,9-13,21,28,30H,8H2,1-2H3,(H,26,33)/t21-/m1/s1 |
| InChIKey | GXMCYYWDRPHQCH-OAQYLSRUSA-N |
| XLogP | 3.49 |
| TPSA | 100.00 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.49 |
| LogP ≤ 5 | 3.49 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142460267 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.